Advertisement

Topics

Cardiatis S.A. Company Profile

18:55 EDT 20th June 2018 | BioPortfolio

Cardiatis is a commercial stage medical technology company developing disease modifying endovascular solutions to thoracoabdominal aneurysms. Cardiatis lead product is the Cardiatis C5, a second generation multilayer flow modulating device indicated for true degenerative Crawford V thoracoabdominal aneurysms with diameters in the 5.5- to 7-cm range.


News Articles [1 Associated News Articles listed on BioPortfolio]

Cardiatis SA Product Pipeline Analysis, 2017 Update [Report Updated: 27122017] Prices from USD $750

SummaryCardiatis SA Cardiatis is a medical device company that develops a multilayer technology platform for endovascular aneurysm. The company offers a three dimensional multilayer braided stent syst...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Cardiatis S.A.

Cardiatis is a commercial stage medical technology company developing disease modifying endovascular solutions to thoracoabdominal aneurysms. Cardiatis lead product is the Cardiat...

More Information about "Cardiatis S.A." on BioPortfolio

We have published hundreds of Cardiatis S.A. news stories on BioPortfolio along with dozens of Cardiatis S.A. Clinical Trials and PubMed Articles about Cardiatis S.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cardiatis S.A. Companies in our database. You can also find out about relevant Cardiatis S.A. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record